Phacilitate Leaders Europe

  • 09:00, 11 Sep 18 - 18:00, 12 Sep 18
  • The Royal Lancaster, London
  • Print page

The Evolution of Advanced Therapies

Advanced therapies is one of the most innovative industries of our time. How do we continue to adapt and evolve for sustainable success?

These kinds of questions will be at the heart of discussions at Phacilitate Leaders Europe in London this September. Not only will your questions be answered, but you’ll find solutions at the event for each and every challenge that you’re currently experiencing, or could experience in the future.

The interactive agenda will cover some of the most talked about topics in the industry including pricing and reimbursement, patient access and regulatory changes. Key opinion leaders taking the stage to present on these topics include: 

  1. Dr. Usman ”Oz”  Azam, President CEO, Tmunity Therapeutics
  2. Doug Danison, Vice President and Head of Access, Value, and Evidence Strategy (AVES), bluebird bio
  3. Dr Drew Hope, Director, Quality Operations, Autolus
  4. Dr Bruce Levine Barbara and Edward Netter Professor in Cancer Gene Therapy, Center for Cellular Immunotherapies of the University of Pennsylvania and President Elect, International Society for Cell and Gene Therapy
  5. Dr Helen Tayton-Martin, Chief Business Officer, Adaptimmune
  6. Dr. Jasper Bos, Vice President and Head of Healthcare, Merck Ventures
  7. Dr Anthony Davies, President, Dark Horse Consulting
  8. Jayne Spink, Chief Executive, Genetic Alliance
  9. Janet Glassford, Senior Quality Assessor, Medicines and Healthcare Products Regulatory Agency (MHRA)
  10. Michela Gabaldo, Head, Alliance Management & Regulatory Affairs, San Raffaele-Telethon Institute for Gene Therapy

Check out the full speaker list here

Phacilitate has grown in step with the industry since 2005 and we care about what happens next. You told us what your challenges are and you can find solutions to each and every one at Phacilitate Leaders Europe this September. 

Join us at Phacilitate Leaders Europe to learn how advanced therapies will continue to evolve and find game changing and tangible solutions that will drive commercial success.

10% off for BIA members (discount code: BIA10)

dfs

Register